These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

27 related articles for article (PubMed ID: 37520127)

  • 1. Cellular mechanisms of fibrin (ogen): insight from neurodegenerative diseases.
    Wen T; Zhang Z
    Front Neurosci; 2023; 17():1197094. PubMed ID: 37529232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Editorial: Imaging of the blood-brain barrier in Alzheimer's disease and related disorders.
    Uchida Y; Shao X; Montagne A; Matsukawa N
    Front Aging Neurosci; 2023; 15():1252581. PubMed ID: 37520129
    [No Abstract]   [Full Text] [Related]  

  • 3. Aggregation and beyond: alpha-synuclein-based biomarkers in synucleinopathies.
    Chopra A; Outeiro TF
    Brain; 2024 Jan; 147(1):81-90. PubMed ID: 37526295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dementia incidence and population-attributable fraction for dementia risk factors in Republic of Korea: a 12-year longitudinal follow-up study of a national cohort.
    Hwangbo S; Lee JY; Han G; Chun MY; Jang H; Seo SW; Na DL; Won S; Kim HJ; Lim DH
    Front Aging Neurosci; 2023; 15():1126587. PubMed ID: 37520131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex differences in alpha-synucleinopathies: a systematic review.
    Raheel K; Deegan G; Di Giulio I; Cash D; Ilic K; Gnoni V; Chaudhuri KR; Drakatos P; Moran R; Rosenzweig I
    Front Neurol; 2023; 14():1204104. PubMed ID: 37545736
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicohort cross-sectional study of cognitive and behavioural digital biomarkers in neurodegeneration: the Living Lab Study protocol.
    Crook-Rumsey M; Daniels SJC; Abulikemu S; Lai H; Rapeaux A; Hadjipanayi C; Soreq E; Li LM; Bashford J; Jeyasingh-Jacob J; Gruia DC; Lambert D; Weil R; Hampshire A; Sharp DJ; Haar S
    BMJ Open; 2023 Aug; 13(8):e072094. PubMed ID: 37536971
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Linking Heat Shock Protein 70 and Parkin in Parkinson's Disease.
    Zhao Z; Li Z; Du F; Wang Y; Wu Y; Lim KL; Li L; Yang N; Yu C; Zhang C
    Mol Neurobiol; 2023 Dec; 60(12):7044-7059. PubMed ID: 37526897
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synucleinopathies: Intrinsic and Extrinsic Factors.
    Lomeli-Lepe AK; Castañeda-Cabral JL; López-Pérez SJ
    Cell Biochem Biophys; 2023 Sep; 81(3):427-442. PubMed ID: 37526884
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Future Directions for Developing Non-dopaminergic Strategies for the Treatment of Parkinson's Disease.
    van Wamelen DJ; Leta V; Chaudhuri KR; Jenner P
    Curr Neuropharmacol; 2024; 22(10):1606-1620. PubMed ID: 37526188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. No laughing white matter: Reduced integrity of the cortical cholinergic pathways in Parkinson's disease-related cognitive impairment.
    Crockett RA; Wilkins KB; Aditham S; Brontë-Stewart HM
    Neurobiol Dis; 2023 Sep; 185():106243. PubMed ID: 37524210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of Nocturnal Symptoms in Chinese Parkinson's Disease Patients Based on the PDSS-2 Scale: A Multicenter Cross-Sectional Study.
    Su W; Huang P; Ma X; Shang H; Ye Q; Cheng O; Chan P; Liu C; Liu W; Tang B; Wang L; Zhang B; Wang T; Shao M; Xie A; Chen X; Zhu X; Wang J; Tao E; Chen S; Chen H
    J Parkinsons Dis; 2023; 13(6):1061-1071. PubMed ID: 37522220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuropathologic Changes of Alzheimer's Disease and Related Dementias: Relevance to Future Prevention.
    White LR; Corrada MM; Kawas CH; Cholerton BA; Edland SE; Flanagan ME; Montine TJ
    J Alzheimers Dis; 2023; 95(1):307-316. PubMed ID: 37522210
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case clusters of Parkinson's disease.
    Fuller Torrey E; Miller J; Bowler A
    Clin Park Relat Disord; 2023; 9():100211. PubMed ID: 37521816
    [No Abstract]   [Full Text] [Related]  

  • 14. Arteriolosclerosis CSVD: a common cause of dementia and stroke and its association with cognitive function and total MRI burden.
    Hua M; Ma AJ; Liu ZQ; Ji LL; Zhang J; Xu YF; Chen WY; Mao LL
    Front Aging Neurosci; 2023; 15():1163349. PubMed ID: 37520130
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological and nonpharmacological interventions in the treatment of Parkinson's disease.
    Cutson TM; Laub KC; Schenkman M
    Phys Ther; 1995 May; 75(5):363-73. PubMed ID: 7732080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease.
    Gao X
    Front Aging Neurosci; 2023; 15():1247256. PubMed ID: 37520127
    [No Abstract]   [Full Text] [Related]  

  • 17. New drug treatments show neuroprotective effects in Alzheimer's and Parkinson's diseases.
    Hölscher C
    Neural Regen Res; 2014 Nov; 9(21):1870-3. PubMed ID: 25558231
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Postmenopausal hormone therapy and Alzheimer's disease, dementia, and Parkinson's disease: A systematic review and time-response meta-analysis.
    Wu M; Li M; Yuan J; Liang S; Chen Z; Ye M; Ryan PM; Clark C; Tan SC; Rahmani J; Varkaneh HK; Bhagavathula AS
    Pharmacol Res; 2020 May; 155():104693. PubMed ID: 32057896
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Turning On Lights to Stop Neurodegeneration: The Potential of Near Infrared Light Therapy in Alzheimer's and Parkinson's Disease.
    Johnstone DM; Moro C; Stone J; Benabid AL; Mitrofanis J
    Front Neurosci; 2015; 9():500. PubMed ID: 26793049
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.